Glaxosmithkline Llc Drug Patent Portfolio

Glaxosmithkline Llc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Glaxosmithkline Llc News

AnaptysBio Seeks to Dismiss GSK/Tesaro's Rejection of Jemperli Royalty Claims

09 Jan, 2026

GSK CEO: There's nothing quite like the joy of our medications succeeding - The Times

27 Dec, 2025

Forecast for the Over-the-Counter Medications Market from 2024 to 2031 | Consumer Insights - openPR.com

18 Nov, 2025

The Human Aspect of Patents: The Struggle for Essential Medications | IPWatchdog Unleashed

11 Nov, 2025

See More